Barclays Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight

January 10, 2014 7:29 AM EST
Get Alerts BMY Hot Sheet
Price: $74.66 -2.37%

Rating Summary:
    13 Buy, 9 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 16 | Down: 26 | New: 7
Trade BMY Now!
Join SI Premium – FREE
Barclays upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Equalweight to Overweight with a price target of $65.00 (from $52.00).

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $55.03 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades

Related Entities


Add Your Comment